K.H. Link

446 total citations
15 papers, 291 citations indexed

About

K.H. Link is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, K.H. Link has authored 15 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Hepatology. Recurrent topics in K.H. Link's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Renal cell carcinoma treatment (3 papers). K.H. Link is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Renal cell carcinoma treatment (3 papers). K.H. Link collaborates with scholars based in Germany, United Kingdom and Switzerland. K.H. Link's co-authors include Marko Kornmann, Ludger Staib, Benno Traub, B. Rieck, Martina Kron, J. Pillasch, M. H. Schoenberg, Evangelos Papachristou, A. Formentini and Karl Reinhard Aigner and has published in prestigious journals such as Annals of Surgery, British journal of surgery and Seminars in Cancer Biology.

In The Last Decade

K.H. Link

14 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K.H. Link Germany	10	164	71	67	67	52	15	291
P. Maubach Germany	9	131 0.8×	109 1.5×	60 0.9×	25 0.4×	85 1.6×	21	324
J Lokich United States	6	342 2.1×	87 1.2×	98 1.5×	55 0.8×	38 0.7×	7	414
Masahiro Shinoda Japan	12	162 1.0×	167 2.4×	72 1.1×	87 1.3×	53 1.0×	45	359
Masaki Yokota Japan	6	153 0.9×	141 2.0×	71 1.1×	150 2.2×	29 0.6×	15	328
Grage Tb United States	5	194 1.2×	77 1.1×	68 1.0×	98 1.5×	44 0.8×	10	306
Stefania Di Girolamo Italy	11	147 0.9×	101 1.4×	145 2.2×	86 1.3×	37 0.7×	28	330
Piotr Spychalski Poland	10	127 0.8×	94 1.3×	106 1.6×	68 1.0×	62 1.2×	34	324
Junjie Hu China	10	87 0.5×	84 1.2×	53 0.8×	60 0.9×	96 1.8×	19	302
Valentina Agostini Italy	12	83 0.5×	95 1.3×	86 1.3×	63 0.9×	51 1.0×	22	366
Toshiya Takeda Japan	9	245 1.5×	164 2.3×	138 2.1×	25 0.4×	41 0.8×	24	371

Countries citing papers authored by K.H. Link

Since Specialization

Citations

This map shows the geographic impact of K.H. Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.H. Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.H. Link more than expected).

Fields of papers citing papers by K.H. Link

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.H. Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.H. Link. The network helps show where K.H. Link may publish in the future.

Co-authorship network of co-authors of K.H. Link

This figure shows the co-authorship network connecting the top 25 collaborators of K.H. Link. A scholar is included among the top collaborators of K.H. Link based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.H. Link. K.H. Link is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Traub, Benno, K.H. Link, & Marko Kornmann. (2021). Curing pancreatic cancer. Seminars in Cancer Biology. 76. 232–246. 32 indexed citations

Kornmann, Marko, A. Formentini, Doris Henne‐Bruns, et al.. (2008). Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatment. European Journal of Surgical Oncology. 34(12). 1316–1321. 42 indexed citations

Link, K.H., et al.. (2008). Koexistenz von zwei unterschiedlichen neuroendokrinen Tumoren des oberen Gastrointestinaltraktes und des Pankreas. DMW - Deutsche Medizinische Wochenschrift. 123(49). 1472–1477.

Link, K.H., et al.. (2005). Increase of Survival Benefit in Advanced Resectable Colon Cancer by Extent of Adjuvant Treatment. Annals of Surgery. 242(2). 178–187. 33 indexed citations

Link, K.H., Susanne Merkel, J. Göhl, et al.. (2004). Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC).. PubMed. 24(1). 385–91. 5 indexed citations

Papachristou, Evangelos, K.H. Link, & M. H. Schoenberg. (2003). Regional celiac artery infusion in the adjuvant treatment of pancreatic cancer.. PubMed. 23(2A). 831–4. 16 indexed citations

Neoptolemos, John P., Janet Dunn, Jennifer Almond, et al.. (2001). Association of upper gastrointestinal surgeons of Great Britain and Ireland. British journal of surgery. 88(3). 475–475. 5 indexed citations

Link, K.H., Gerd Leder, J. Pillasch, et al.. (1998). In vitro concentration response studies and in vitro phase II tests as the experimental basis for regional chemotherapeutic protocols. Seminars in Surgical Oncology. 14(3). 189–201. 35 indexed citations

Neoptolemos, John P., David Kerr, H. G. Beger, et al.. (1997). ESPAC-1 Trial Progress Report: The European Randomized Adjuvant Study Comparing Radiochemotherapy, 6 Months Chemotherapy and Combination Therapy versus Observation in Pancreatic Cancer. Digestion. 58(6). 570–577. 30 indexed citations

10.

Porzsolt, Franz, Regine Mayer‐Steinacker, M. Schulte, et al.. (1996). Quality assurance by specification and achievement of goals in palliative cancer treatment. Cancer Treatment Reviews. 22. 41–49. 5 indexed citations

11.

Link, K.H., Marko Kornmann, Gerhard Leder, et al.. (1996). Regional chemotherapy directed by individual chemosensitivity testing in vitro: a prospective decision-aiding trial.. PubMed. 2(9). 1469–74. 19 indexed citations

12.

Link, K.H., et al.. (1991). Correlation of serum ibuprofen concentration with clinical signs of toxicity in three canine exposures.. PubMed. 33(5). 486–8. 6 indexed citations

13.

Link, K.H., et al.. (1987). Rationale and indications for perfusion in liver tumors: Current data. World Journal of Surgery. 11(4). 534–540. 29 indexed citations

14.

Aigner, Karl Reinhard, et al.. (1984). Die isolierte Leberperfusion bei fortgeschrittenen Metastasen kolorektaler Karzinome. Oncology Research and Treatment. 7(1). 13–21. 22 indexed citations

15.

Link, K.H., et al.. (1983). Antihypertensive effect of hydrochlorothiazide administered once or twice daily.. PubMed. 1(3). 239–43. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact